adverse events Archives - Page 12 of 13 - Health Freedom Defense Fund

Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis

This study highlights the unique danger from mRNA shots, of events like myocarditis and pericarditis, compared to other pharmaceutical products.

First-Trimester mRNA COVID-19 Vaccination and Risk of Major Congenital Anomalies

This is an instructive study on how data can be manipulated in a peer reviewed journal through exclusion-- in this case, any fetus with a severe enough defect to lead to termination or fetal death was ignored. Statistical tests suggest hiding of signal.

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

Expansive study of over 99 million people in Vaccine, which analyzes the outcomes for those who took mRNA and viral vector injections, and confirms well-known side effects of note, and identifies new adverse events for further investigation.

Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers.

Study of 1,745 healthcare workers finds mRNA boosters raise risk of influenza-like illness by up to 70% and increase workdays lost by 50%.

Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic

Early research from Czech Republic indicated a significantly lower rate of successful conceptions (live birth at 9 months) among those mothers who were vaccinated. Not controlled for confounding variables but an early look at a subsequently well-documented phenomenon of menstrual and pregnancy-related issues with the mRNA platform.

Expression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for hemorrhagic stroke Post-mRNA vaccination

Japanese scientists published a recent study showing new evidence of COV-19 mRNA vaccine spike protein persisting in cerebral arteries of 43.8% of haemorrhagic stroke patients up to 17 months post-vaccination with absence of infection, expressing concerns about vaccine biodistribution and long-term safety.